Search Orphan Drug Designations and Approvals
-
Generic Name: | N-(N-(4-(trifluoromethoxy)phenyl) carbamimidoyl)pyrrolidine-1-carboximidamide acetate (Or N1-(4-trifluoromethoxy)phenyl-N5-pyrrolidine biguanide acetate) |
---|---|
Date Designated: | 02/01/2021 |
Orphan Designation: | Treatment of Idiopathic Pulmonary Fibrosis |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
ImmunoMet Therapeutics Inc. 2450 Holcombe Houston, Texas 77021 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-